Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Gldcem1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Gldcem1flox/Cya

Common Name
Gldc-flox
Product ID
S-CKO-18297
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-104174-Gldc-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Gldc-flox Mouse (Catalog S-CKO-18297) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Gldc-flox
Strain ID
CKOCMP-104174-Gldc-B6J-VB
Gene Name
Gldc
Product ID
S-CKO-18297
Gene Alias
D19Wsu57e, b2b2679Clo, D030049L12Rik
Background
C57BL/6JCya
Gene Full Name
glycine decarboxylase
Modification
Conditional knockout
NCBI ID
104174 (Mouse)
Phenotype
MGI:1341155
Chromosome
Chr 19 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000025778
NCBI Transcript ID
NM_138595.2
Target Region
Exon 3
Size of Effective Region
~1.4 kb
Overview of Gene Research
Gldc, or glycine decarboxylase, is a core enzyme in the glycine cleavage system located on the mitochondrial membrane. It is responsible for regulating glycine levels, contributing one-carbon units to folate metabolism, and is crucial for normal development and metabolism [3].

Mutations in Gldc are the main cause of classic nonketotic hyperglycinemia (NKH), with 80% of subjects in a study having Gldc mutations [1]. In a zebrafish model of Gldc deficiency, embryos showed renal, craniofacial, and neural development defects, indicating its essential role in renal progenitor patterning during kidney development [3].

In cancer research, in prostate cancer, Gldc plays a central role in glycolysis, enhances aerobic glycolysis, and promotes cell migration, invasion, and immune escape [2]. In TNBC, Gldc is up-regulated, promotes cell proliferation, and is correlated with tumor immune infiltration [4]. In colorectal cancer, Gldc promotes metastasis through the Hippo signaling pathway-mediated epithelial-mesenchymal transition [5].

In conclusion, Gldc is essential for regulating glycine metabolism and has a significant impact on development and disease. Its role in NKH and various cancers, as revealed by genetic models such as zebrafish and through studies in human subjects, provides valuable insights into potential therapeutic targets for these diseases.

References:
1. Coughlin, Curtis R, Swanson, Michael A, Kronquist, Kathryn, Scharer, Gunter H, Van Hove, Johan L K. 2016. The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT. In Genetics in medicine : official journal of the American College of Medical Genetics, 19, 104-111. doi:10.1038/gim.2016.74. https://pubmed.ncbi.nlm.nih.gov/27362913/
2. Chen, Ming-Kun, Xiao, Zhuo-Yu, Huang, Zhi-Peng, Liu, Yang, Zhao, Shan-Chao. 2023. Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer. In International journal of biological sciences, 19, 4726-4743. doi:10.7150/ijbs.85893. https://pubmed.ncbi.nlm.nih.gov/37781511/
3. Weaver, Nicole E, Healy, Allison, Wingert, Rebecca A. 2022. gldc Is Essential for Renal Progenitor Patterning during Kidney Development. In Biomedicines, 10, . doi:10.3390/biomedicines10123220. https://pubmed.ncbi.nlm.nih.gov/36551976/
4. Xie, Huaying, Yan, Tingting, Lu, Xinxin, Zhou, Liheng, Ma, Jun. 2022. GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC. In Frontiers in immunology, 13, 1033367. doi:10.3389/fimmu.2022.1033367. https://pubmed.ncbi.nlm.nih.gov/36275705/
5. Yu, Hao, Hu, Xueqing, Zhang, Yingru, Wang, Yan, Zhu, Huirong. 2023. GLDC promotes colorectal cancer metastasis through epithelial-mesenchymal transition mediated by Hippo signaling pathway. In Medical oncology (Northwood, London, England), 40, 293. doi:10.1007/s12032-023-02076-9. https://pubmed.ncbi.nlm.nih.gov/37668829/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research